Adverse effects of biological agents in the treatment of psoriasis

Franco Rongioletti, Martina Burlando, Aurora Parodi

Research output: Contribution to journalArticle

Abstract

Tumour necrosis factor (TNF) antagonists are generally well tolerated, but carry the risk of side effects. In patients with psoriasis, the potential risks with anti-TNF agents may be overestimated because the most commonly reported adverse events are based on studies in patients with rheumatoid arthritis or inflammatory bowel disease. Whereas patients with psoriasis typically receive monotherapy, these patients are treated with biological-based combination therapies. Furthermore, patients with psoriasis have distinctive and different comorbidities, which could play a role in the development of different adverse events. However, the potential risks of the use of biological agents should always be taken into consideration.

Original languageEnglish
Pages (from-to)35-37
Number of pages3
JournalAmerican Journal of Clinical Dermatology
Volume11
Issue numberSUPPL. 1
Publication statusPublished - 2010

    Fingerprint

ASJC Scopus subject areas

  • Dermatology

Cite this